CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) EV-to-Revenue : 1.88 (As of May. 01, 2024)

View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CSPC Pharmaceutical Group's enterprise value is $8,319 Mil. CSPC Pharmaceutical Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $4,419 Mil. Therefore, CSPC Pharmaceutical Group's EV-to-Revenue for today is 1.88.

The historical rank and industry rank for CSPC Pharmaceutical Group's EV-to-Revenue or its related term are showing as below:

CHJTF' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.6 Med: 2.54 Max: 10.85
Current: 1.87

During the past 13 years, the highest EV-to-Revenue of CSPC Pharmaceutical Group was 10.85. The lowest was 1.60. And the median was 2.54.

CHJTF's EV-to-Revenue is ranked better than
59.57% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.35 vs CHJTF: 1.87

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-01), CSPC Pharmaceutical Group's stock price is $0.75. CSPC Pharmaceutical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.37. Therefore, CSPC Pharmaceutical Group's PS Ratio for today is 2.02.

CSPC Pharmaceutical Group EV-to-Revenue Historical Data

The historical data trend for CSPC Pharmaceutical Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group EV-to-Revenue Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

4.50

2.91

2.61

2.45

2.18

CSPC Pharmaceutical Group Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															2.45	2.60	2.00	1.97	2.18

Competitive Comparison of CSPC Pharmaceutical Group's EV-to-Revenue

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSPC Pharmaceutical Group's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's EV-to-Revenue falls into.

CSPC Pharmaceutical Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

CSPC Pharmaceutical Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	8318.855	/	4418.571
	=	1.88

CSPC Pharmaceutical Group's current Enterprise Value is $8,319 Mil.
CSPC Pharmaceutical Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,419 Mil.

CSPC Pharmaceutical Group (OTCPK:CHJTF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

CSPC Pharmaceutical Group's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.75	/	0.372
	=	2.02

CSPC Pharmaceutical Group's share price for today is $0.75.
CSPC Pharmaceutical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.37.

CSPC Pharmaceutical Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (OTCPK:CHJTF) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

CSPCY:USA 01093:Hong Kong CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Headlines

From GuruFocus

Value Partners Classic Fund Comments on CSPC Pharmaceutical

By Vera Yuan Vera Yuan • 07-29-2014